Waters Corporation (WAT)
Healthcare · end-of-day data as of Oct 16, 2026
The average 12-month analyst price target for WAT is $456.07, 4.4% above the last close of $436.95 on Oct 16, 2026; targets range from $394.66 to $517.80. Rating consensus: Buy.
Snapshot
- P/E109.0x
- P/E vs sector+287.0%
- P/E vs own+123.1%
- Target upside+4.4%
- ConsensusBuy
- Market cap$42.9B
- FCF yield+0.9%
- Insiders-$1.44M
- Earnings in18d
- News0.00
Why it moved
Waters Corporation (WAT) fell 1.6% on Oct 16, 2026.
The market (SPY) fell 1.1%; Healthcare stocks fell 0.7%. Most of the move came from the market as a whole.
0 stories on the day (30-day average 0.3).
Market = SPY. Sector = equal-weight average of the tracked companies in the same sector, net of the market.
Price and events
Last close $436.95 · +30.5% over 1y · E earnings · D dividend · S split · A analyst rating change
Technicals
- Trendsideways
- Sector▲ +16.0%
- MAs20▲ 50▲ 100▲ 200▲
- Above MAs4 of 4 above
- MA20×50—
- RSI56
- Support-4.2%
- Resistance—
- Off 52w high-1.6%
- Off ATH-1.6%
- 52w range$436.95
- Bollingerupper half
- MACD-0.45
- ATR+2.9%
- Volume1.0x
Analyst price targets
14 firms with a target in the last 12 months · last close $436.95 · as of Oct 16, 2026
Strong buy 3 · Buy 15 · Hold 6 · Sell 0 · Strong sell 0
Revenue and free cash flow
Q2 FY2026: Revenue +113.3% year over year, free cash flow 9.3% of revenue, operating margin -5.2%.
| Q2 FY2026 | Jul 4, 2026 | $1.65B | -1.39 | $153M | 44.6% | -5.2% | -8.3% |
| Q1 FY2026 | Apr 4, 2026 | $1.27B | -0.87 | -$42M | 47.0% | -3.7% | -5.7% |
| Q4 FY2025 | Dec 31, 2025 | $932M | 3.77 | $126M | 59.8% | 33.3% | 24.2% |
| Q3 FY2025 | Sep 27, 2025 | $800M | 2.50 | $162M | 59.0% | 24.0% | 18.6% |
| Q2 FY2025 | Jun 28, 2025 | $771M | 2.47 | $18.55M | 58.3% | 24.4% | 19.1% |
| Q1 FY2025 | Mar 29, 2025 | $662M | 2.03 | $234M | 58.2% | 22.9% | 18.3% |
| Q4 FY2024 | Dec 31, 2024 | $873M | 3.88 | $188M | 60.1% | 33.5% | 26.5% |
| Q3 FY2024 | Sep 28, 2024 | $740M | 2.71 | $179M | 59.3% | 28.5% | 21.8% |
Peers
| 20D | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1 |  | $172.97 | -1.5% | -1.5% | +0.5% | 34.0 | $48.77B | |
| 2 |  | $560.36 | +2.4% | -26.9% | +34.9% | 39.7 | $44.15B | |
| 3 |  | $266.90 | -1.5% | -3.0% | +3.6% | 33.1 | $43.93B | |
| 4 | | $436.95 | -1.6% | -1.6% | +4.4% | 109.0 | $42.9B | |
| 5 |  | $262.54 | -2.0% | -10.6% | -16.6% | 49.0 | $39.64B | |
| 6 |  | $1,622.29 | -1.0% | -1.0% | -7.3% | 36.5 | $32.51B | |
| 7 |  | $235.00 | -1.7% | -4.7% | -0.5% | 24.9 | $25.94B | |
| 8 |  | $317.95 | -2.2% | -6.1% | +5.8% | 26.3 | $25.79B |
Data as of Oct 16, 2026 close.
Latest news
Sentiment classified by AI from the headline (green positive, red negative). Links open the publisher.